ALA 3.23% 15.0¢ arovella therapeutics limited

New Baker interview, page-12

  1. 8,805 Posts.
    lightbulb Created with Sketch. 1692
    Again just talk, nothing new, no mention about stride, no reason given for Teva MAA being 12 months late.

    I would go as far as saying all this b.s has been put out before, instead of telling us his life story he needs to get off his behind and start getting current deals delivering revenue, all this talking without results not going to get the market excited.

    Deals with big up front payments, current deals at least delivering the milestone payments is what is needed.

    Are they trying to bluff their way until the Zolpimist MAA outcome is known.

    So far I am disappointed in both Hopper and Baker
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.0¢
Change
-0.005(3.23%)
Mkt cap ! $157.6M
Open High Low Value Volume
15.5¢ 15.5¢ 15.0¢ $63.39K 414.8K

Buyers (Bids)

No. Vol. Price($)
8 384976 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 228483 5
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.